Lenders have agreed to keep 31 assets together, ending almost a whole year of uncertainty for the private healthcare giant ...

By Maggie Fick LONDON, Feb 5 (Reuters) - Novo Nordisk CEO Mike Doustdar was in a meeting with investors on Thursday ...

The guide to how much GLP-1 medications cost, including Ozempic, Wegovy, and Zepbound.

Early managed care prioritized coordinated primary care “gatekeeping,” selective contracting, utilization/quality controls, ...

An informational overview examining compounded semaglutide vs FDA-approved GLP-1 medications, telehealth platform evaluation ...

Guidance for 2026 EPS increased from a reaffirmed 2025 outlook of at least $29.60 per share in Q3 to at least $30.25 per share for 2026 in Q4.

Brevard Achievement Center (BAC)recently a series of personnel moves that the organization says reflects its continued growth ...

Technology roles are changing as artificial intelligence forces a shift toward human management positions.

LeanTaaS named Best in KLAS for capacity optimization for the second year, earning top scores and strong customer loyalty ...

Investors across the board have been selling off software stocks because of the potential ubiquity of AI - and SaaS companies ...

UK M&A activity in 2025 showed early signs of recovery, according to PwC’s latest global M&A industry trends 2026 outlook.

AFFO guidance for 2026 was newly introduced at $3.15-$3.25 per share, compared to previous quarter's focus on 2025 guidance. Sabra is expected to become Omega's largest revenue source by year-end, ...